文献速递关节外科

医院衰弱风险评分不能准确预测全关节置换患者的治疗费用

The Hospital Frailty Risk Score is Not an Accurate Predictor of Treatment Costs for Total Joint Replacement Patients in a Medicare Bundled Payment Population.
PubMed 文献 · J Arthroplasty · 2021-03-30

本研究回顾性分析了2015至2020年间单一大骨科诊所接受初次全关节置换术的4936例患者,评估医院衰弱风险评分(HFRS)对高治疗费用的预测效度。结果显示HFRS对高发作期费用的预测敏感性仅49%、特异性66%,但能较好预测术后再入院和并发症。

要点

  • HFRS对全关节置换高费用的预测敏感性差(49%),不适用于费用风险调整。
  • HFRS对术后再入院和并发症有足够特异性,可辅助识别高风险患者。
  • 患者年龄和性别是比HFRS更优的个体费用预测因素。

核心结论

  • HFRS作为全关节置换患者高发作期费用的预测工具敏感性差,但预测术后再入院和并发症的特异性尚可。

研究设计与样本

  • 回顾性分析2015至2020年单一大骨科诊所接受初次全关节置换术的患者,使用ICD-10编码计算HFRS,收集住院、急性后期和发作期费用数据。

主要发现

  • 4936例患者有可计算的HFRS,中、高分患者术后再入院/并发症更频繁且发作期费用更高。
  • HFRS预测发作期费用的敏感性为49%、特异性为66%。
  • 多变量分析显示年龄和性别是比HFRS更优的个体费用预测因素。

关键数值与推荐

  • HFRS预测高发作期费用敏感性49%、特异性66%。
  • HFRS预测术后再入院和并发症特异性足够但临床应用仍不理想。

临床怎么用

  • HFRS不宜单独用于全关节置换捆绑支付模型中的费用风险调整。
  • HFRS可辅助识别术后再入院和并发症高风险患者。

局限性

  • 单中心回顾性研究,HFRS基于ICD-10编码计算可能存在编码偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Medically complex patients require more resources and experience higher costs within total joint arthroplasty (TJA) bundled payment models. While risk adjustment would be beneficial for such patients, no tool currently exists which can reliably identify these patients preoperatively. The purpose of this study is to determine if the Hospital Frailty Risk Score (HFRS) is a valid predictor of high-TJA treatment costs. METHODS: Retrospective analysis was performed on patients who underwent primary TJA between 2015 and 2020 from a single large orthopedic practice. ICD-10 codes from an institutional database were used to calculate HFRS. Cost data including inpatient, postacute, and episode of care (EOC) costs were collected. Charlson comorbidity index, demographics, readmissions, and complications were analyzed. RESULTS: 4936 patients had a calculable HFRS and those with intermediate and high scores experienced more frequent readmissions/complications after TJA, as well as higher EOC costs. However, HFRS did not reliably predict EOC costs, yielding a sensitivity of 49% and specificity of 66%. Multivariate analysis revealed that both patient age and sex are superior individual cost predictors when compared with HFRS. Secondary analyses indicated that HFRS more effectively predicts TJA complications and readmissions but is still nonideal for clinical applications. CONCLUSION: HFRS has poor sensitivity as a predictor of high-EOC costs for TJA patients but has adequate specificity for predicting postoperative readmissions and complications. Further research is needed to develop a scale that can appropriately predict orthopedic cost outcomes.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Ong CB, Krueger CA, Star AM, et al. The Hospital Frailty Risk Score is Not an Accurate Predictor of Treatment Costs for Total Joint Replacement Patients in a Medicare Bundled Payment Population. J Arthroplasty. 2021. PMID: 33893001. doi:10.1016/j.arth.2021.03.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。